NewLink Genetics (NLNK) Tops Q3 EPS by 6c

NewLink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.54), $0.06 better than the analyst estimate of ($0.60). Revenue for the quarter came in at $15.35 million versus the consensus estimate of $3.83 million.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c